These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15517388)

  • 1. Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.
    Walker SM; McKinstry B; Boray JC; Brennan GP; Trudgett A; Hoey EM; Fletcher H; Fairweather I
    Parasitol Res; 2004 Dec; 94(6):427-38. PubMed ID: 15517388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an egg hatch assay for the diagnosis of triclabendazole resistance in Fasciola hepatica: proof of concept.
    Fairweather I; McShane DD; Shaw L; Ellison SE; O'Hagan NT; York EA; Trudgett A; Brennan GP
    Vet Parasitol; 2012 Feb; 183(3-4):249-59. PubMed ID: 21821359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of multiple life stages of two Australian Fasciola hepatica isolates in sheep.
    George SD; Baker K; Lake L; Vanhoff K; D'Arcy R; Emery D; Rolfe PF
    Vet Parasitol; 2017 Dec; 248():4-9. PubMed ID: 29173540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2011 Oct; 109(4):981-95. PubMed ID: 21442257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tegumental surface changes in adult Fasciola hepatica in response to treatment in vivo with triclabendazole in the sheep host.
    Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
    Vet Parasitol; 2010 Sep; 172(3-4):238-48. PubMed ID: 20627418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Vet Parasitol; 2011 May; 177(3-4):305-15. PubMed ID: 21208747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole.
    Halferty L; Brennan GP; Hanna RE; Edgar HW; Meaney MM; McConville M; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2008 Aug; 155(1-2):49-58. PubMed ID: 18511199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke.
    Meaney M; Allister J; McKinstry B; McLaughlin K; Brennan GP; Forbes AB; Fairweather I
    Parasitol Res; 2006 Oct; 99(5):609-21. PubMed ID: 16896655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil.
    Meaney M; Savage J; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Parasitology; 2013 Sep; 140(10):1287-303. PubMed ID: 23756576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasciola hepatica: Histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally infected hosts.
    Hanna RE; Edgar H; Moffett D; McConnell S; Fairweather I; Brennan GP; Trudgett A; Hoey EM; Cromie L; Taylor SM; Daniel R
    Vet Parasitol; 2008 Nov; 157(3-4):222-34. PubMed ID: 18774647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the microtubule inhibitor tubulozole-C on the tegument of triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.
    Robinson MW; Trudgett A; Hoey EM; Fairweather I
    Parasitol Res; 2003 Sep; 91(2):117-29. PubMed ID: 12910417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the P-glycoprotein inhibitor, R(+)-verapamil on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Vet Parasitol; 2013 Jul; 195(1-2):72-86. PubMed ID: 23597772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.
    McConville M; Brennan GP; Flanagan A; Edgar HW; Hanna RE; McCoy M; Gordon AW; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2009 May; 162(1-2):75-88. PubMed ID: 19282108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fasinex (triclabendazole)--a new fasciolicide].
    Eckert J; Schneiter G; Wolff K
    Berl Munch Tierarztl Wochenschr; 1984 Oct; 97(10):349-56. PubMed ID: 6517845
    [No Abstract]   [Full Text] [Related]  

  • 15. Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
    McConville M; Brennan GP; McCoy M; Castillo R; Hernandez-Campos A; Ibarra F; Fairweather I
    Parasitology; 2006 Aug; 133(Pt 2):195-208. PubMed ID: 16650337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage-specific differences in fecundity over the life-cycle of two characterized isolates of the liver fluke, Fasciola hepatica.
    Walker SM; Hoey E; Fletcher H; Brennan G; Fairweather I; Trudgett A
    Parasitology; 2006 Aug; 133(Pt 2):209-16. PubMed ID: 16597358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
    Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
    Vet Parasitol; 2010 Dec; 174(3-4):218-27. PubMed ID: 20933333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasciola hepatica: tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether.
    Keiser J; Morson G
    Exp Parasitol; 2008 Feb; 118(2):228-37. PubMed ID: 17888906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasciola hepatica: comparative effects of host resistance and parasite intra-specific interactions on size and reproductive histology in flukes from rats infected with isolates differing in triclabendazole sensitivity.
    Hanna RE; Gordon AW; Moffett D; Edgar HW; Oliver LF; McConnell S; Shaw L; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Jun; 178(3-4):251-63. PubMed ID: 21333449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitology; 2009 Feb; 136(2):183-92. PubMed ID: 19079818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.